Driven by a commitment to patients, and guided by genomic insights, Aevi Genomic Medicine strives to
patients navigate through the complexities of their disease.
The company’s research and development efforts include an ongoing collaboration with a leading
academic medical center.
Our Company Strategy
- Developing therapies for children and adults with pediatric onset life altering diseases
- Collaborating with patients, families, and advocacy groups to increase awareness of the
genomic-basis of disease, support research, and improve access to therapies
Genomic Medicine Platform
- Leverage an understanding of the genomic basis of disease to develop new and differentiated
- Applying broad capabilities in genomically guided drug development to derisk development